Table 1.
Key study covariates of US and UK/ROI patients
| Patient characteristics | US (n = 219) | UK/ROI (n = 194) | ||
|---|---|---|---|---|
| N = 413 (%)a | n (%) | n (%) | χ2 | |
| Age, mean (SD)b | 60.22 (15.90) | 68.60 (9.80) | 50.71 (16.17) | 189.43*** c |
| Race | 0.15 | |||
| White | 377 (91.3) | 201 (91.8) | 176 (90.7) | |
| Other | 36 (8.7) | 18 (8.2) | 18 (9.3) | |
| Education | 0.29 | |||
| No college education | 222 (53.8) | 115 (52.5) | 107 (55.2) | |
| College education | 191 (46.2) | 104 (47.5) | 87 (44.8) | |
| Incomed | 17.34*** | |||
| Less than $50k/£40k | 213 (53.3) | 90 (43.3) | 123 (64.1) | |
| Greater than $50k/£40k | 187 (46.8) | 118 (56.7) | 69 (35.90) | |
| Sex | 1.22 | |||
| Male | 180 (43.6) | 101 (46.1) | 79 (40.7) | |
| Female | 233 (56.4) | 118 (53.9) | 115 (59.3) | |
| Cancer status | 53.32*** | |||
| Remission | 309 (74.8) | 196 (89.5) | 113 (58.2) | |
| Currently has cancer | 104 (25.2) | 23 (10.5) | 81 (41.8) | |
| Cancer type | 11.95** | |||
| Breast | 197 (47.7) | 93 (42.5) | 104 (53.6) | |
| Colorectal | 54 (13.1) | 27 (12.3) | 27 (13.9) | |
| Lung or bronchus | 32 (7.7) | 14 (6.4) | 918 (9.3) | |
| Prostate | 130 (31.5) | 85 (38.8) | 45 (23.2) | |
| Ask CCT | 1.61 | |||
| No | 397 (96.1) | 213 (97.3) | 184 (94.8) | |
| Yes | 16 (3.9) | 6 (2.7) | 10 (5.2) |
Ask CCT, patient previously asked to participate in a cancer clinical trial
a
Percentages totaled within column may exceed 100% due to rounding
b
Patients who failed to respond were removed (n = 1)
c
F statistic derived from a one-way analysis of variance
d
Patients who failed to respond were removed (n = 13)
p ≤ 0.05;
**
p ≤ 0.01;
***
p ≤ 0.001